Literature DB >> 20819843

One-year prevalence of migraine in Spain: a nationwide population-based survey.

Jorge Matías-Guiu1, Jesus Porta-Etessam, Valentín Mateos, Samuel Díaz-Insa, Arturo Lopez-Gil, Cristina Fernández.   

Abstract

AIM: The purpose of the study was to estimate the one-year prevalence of migraine among a population-based sample of Spanish adults.
METHOD: Men and women aged 18-65 years were selected at random according to quotas for age, sex, size of habitat (<10,000 inhabitants, 10,001-50,000 inhabitants, 50,001-200,000 inhabitants and >200,000 inhabitants) and residence proportional to the population size of the geographical location. A random-digit-dial, computer-assisted telephone interview (CATI) survey was conducted between April and July 2006. The 2004 International Headache Society operational diagnostic criteria were applied.
RESULTS: From a total of 70,692 telephone calls and 26,255 (31.7%) valid contacts, 5,668 (21.6%) respondents completed the CATI survey. A total of 476 subjects (8.4%, 95% confidence interval [CI] 7.7-9.1%) with strict migraine and 236 with probable migraine (4.2%, 95% CI 3.7-4.7%) were recorded. The 1-year prevalence of total migraine (N = 712) was 12.6% (95% CI 11.6-13.6) (17.2% in females, 8.0% in males). The prevalence rates showed significant geographic variations, from 7.6% in Navarra to 18% in the Canary Islands. One-half of the subjects had migraine with aura. One-third of subjects were never diagnosed for migraine.
CONCLUSIONS: The one-year prevalence of migraine in Spain is 12.6%, with a prevalence of migraine with and without aura of 8.4% and probable migraine of 4.2%. These findings add data to the current understanding of migraine.

Entities:  

Mesh:

Year:  2010        PMID: 20819843     DOI: 10.1177/0333102410382794

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  10 in total

1.  Persistence, use of resources and costs in patients under migraine preventive treatment: the PERSEC study.

Authors:  Pablo Irimia; David García-Azorín; Mercedes Núñez; Sílvia Díaz-Cerezo; Pepa García de Polavieja; Tommaso Panni; Aram Sicras-Navarro; Antoni Sicras-Mainar; Antonio Ciudad
Journal:  J Headache Pain       Date:  2022-07-07       Impact factor: 8.588

2.  Factors associated with the differences in migraine prevalence rates between Spanish regions.

Authors:  Jorge Matias-Guiu; Cristina Fernandez; Jesús Porta-Etessam; Valentin Mateos; Samuel Diaz-Insa
Journal:  ScientificWorldJournal       Date:  2014-01-30

3.  Analysis of factors influencing telephone call response rate in an epidemiological study.

Authors:  Jorge Matías-Guiu; Pedro Jesús Serrano-Castro; José Ángel Mauri-Llerda; Francisco José Hernández-Ramos; Juan Carlos Sánchez-Alvarez; Marisa Sanz
Journal:  ScientificWorldJournal       Date:  2014-10-21

4.  Psychosocial and Somatosensory Factors in Women with Chronic Migraine and Painful Temporomandibular Disorders.

Authors:  Alfonso Gil-Martínez; Mónica Grande-Alonso; Roy La Touche; Manuel Lara-Lara; Almudena López-López; Josué Fernández-Carnero
Journal:  Pain Res Manag       Date:  2016-10-13       Impact factor: 3.037

5.  Period prevalence of self-reported headache in the general population in Germany from 1995-2005 and 2009: results from annual nationwide population-based cross-sectional surveys.

Authors:  Andreas Straube; Bernhard Aicher; Steffanie Förderreuther; Thomas Eggert; Janin Köppel; Stefan Möller; Roland Schneider; Gunther Haag
Journal:  J Headache Pain       Date:  2013-02-14       Impact factor: 7.277

6.  Economic impact of a triptan Rx-to-OTC switch in six EU countries.

Authors:  Aurelie Millier; Joshua Cohen; Mondher Toumi
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

7.  Prevalence of migraine in Han Chinese of Fujian province: An epidemiological study.

Authors:  Qi-Fang Lin; Qiao-Qing Xia; Yu-Li Zeng; Xiao-Yang Wu; Lin-Feng Ye; Long-Teng Yao; Yong-Tong Xin; Gen-Bin Huang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

8.  OnabotulinumtoxinA infiltration and nerve blocks in patients with headache and neuralgia: safety recommendations to prevent SARS-CoV-2 infection.

Authors:  S Santos-Lasaosa; J Porta-Etessam
Journal:  Neurologia (Engl Ed)       Date:  2020-05-14

9.  Analysis of the management and costs of headache disorders in Spain during the period 2011-2016: a retrospective multicentre observational study.

Authors:  Josep Darbà; Alicia Marsà
Journal:  BMJ Open       Date:  2020-02-13       Impact factor: 2.692

10.  Spectrum of Headaches Associated With SARS-CoV-2 Infection: Study of Healthcare Professionals.

Authors:  Jesús Porta-Etessam; Jordi A Matías-Guiu; Nuria González-García; Patricia Gómez Iglesias; Enrique Santos-Bueso; Pedro Arriola-Villalobos; David García-Azorín; Jorge Matías-Guiu
Journal:  Headache       Date:  2020-07-15       Impact factor: 5.311

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.